Free Trial

Rep. Jonathan L. Jackson Buys Lam Research Corporation (NASDAQ:LRCX) Shares

Lam Research logo with Computer and Technology background

Key Points

  • Representative Jonathan L. Jackson purchased shares of Lam Research Corporation (NASDAQ:LRCX) valued between $1,001 and $15,000 on August 13th, as disclosed on September 23rd.
  • Lam Research reported a quarterly revenue of $5.17 billion, significantly surpassing analysts' expectations of $4.99 billion, along with a net margin of 29.07%.
  • The company has announced a dividend increase to $0.26 per share, up from $0.23, with a scheduled payment date of October 15th.
  • MarketBeat previews top five stocks to own in November.

Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Lam Research Corporation NASDAQ: LRCX. In a filing disclosed on September 23rd, the Representative disclosed that they had bought between $1,001 and $15,000 in Lam Research stock on August 13th. The trade occurred in the Representative's "MORGAN STANLEY - ROLLOVER IRA" account.

Representative Jonathan L. Jackson also recently made the following trade(s):

  • Purchased $15,001 - $50,000 in shares of Doximity NASDAQ: DOCS on 8/25/2025.
  • Sold $1,001 - $15,000 in shares of International Business Machines NYSE: IBM on 8/13/2025.
  • Sold $1,001 - $15,000 in shares of Fomento Economico Mexicano NYSE: FMX on 7/17/2025.
  • Purchased $1,001 - $15,000 in shares of ARM NASDAQ: ARM on 7/17/2025.

Lam Research Trading Up 2.2%

Lam Research stock opened at $131.09 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a one year low of $56.32 and a one year high of $133.57. The stock has a market capitalization of $165.31 billion, a PE ratio of 31.51, a price-to-earnings-growth ratio of 1.62 and a beta of 1.76. The business's fifty day moving average is $106.87 and its 200 day moving average is $90.67.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same period last year, the firm posted $1.03 earnings per share. Lam Research's revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.8%. This is a boost from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Wednesday, September 24th. Lam Research's payout ratio is 25.00%.

Analysts Set New Price Targets

Several equities research analysts recently commented on LRCX shares. Raymond James Financial increased their price objective on Lam Research from $90.00 to $110.00 and gave the company an "outperform" rating in a research report on Thursday, July 31st. The Goldman Sachs Group began coverage on Lam Research in a research report on Thursday, July 10th. They issued a "buy" rating and a $115.00 target price on the stock. Deutsche Bank Aktiengesellschaft raised Lam Research from a "hold" rating to a "buy" rating and raised their target price for the stock from $100.00 to $150.00 in a research report on Monday. Wall Street Zen cut Lam Research from a "buy" rating to a "hold" rating in a research report on Saturday, September 20th. Finally, Wells Fargo & Company set a $98.00 target price on Lam Research and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Twenty-one equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Lam Research presently has a consensus rating of "Moderate Buy" and a consensus target price of $114.83.

Get Our Latest Analysis on LRCX

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Empowered Funds LLC lifted its position in shares of Lam Research by 10.5% during the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company's stock valued at $13,629,000 after buying an additional 17,833 shares in the last quarter. Pinnacle Financial Partners Inc purchased a new position in shares of Lam Research during the 1st quarter valued at about $201,000. Cookson Peirce & Co. Inc. purchased a new position in shares of Lam Research during the 1st quarter valued at about $607,000. China Universal Asset Management Co. Ltd. lifted its position in shares of Lam Research by 27.1% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 49,505 shares of the semiconductor company's stock valued at $3,607,000 after buying an additional 10,565 shares in the last quarter. Finally, First Citizens Bank & Trust Co. lifted its position in shares of Lam Research by 47.8% during the 1st quarter. First Citizens Bank & Trust Co. now owns 121,902 shares of the semiconductor company's stock valued at $8,862,000 after buying an additional 39,414 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois' 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois' 1st Congressional District. He declared candidacy for the 2026 election. Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson's career experience includes working as an investment analyst and an entrepreneur.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Dip: 3 Healthcare Stocks Ready to Recover
3 Options Myths Costing You Money (Do This Instead)
The Best & Worst Stocks in the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines